Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01490 | 34726357 | J Pediatr Endocrinol Metab | Increased hepcidin levels and non-alcoholic fatty liver disease in obese prepubertal children: a further piece to the complex puzzle of metabolic derangements. | 2021 | Details |
| A01492 | 34726148 | Proc Nutr Soc | Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism. | 2021 | Details |
| A01496 | 34724062 | J Clin Endocrinol Metab | The Effect of High-intensity Interval Training vs Moderate-intensity Continuous Training on Liver Fat: A Systematic Review and Meta-Analysis. | 2022 | Details |
| A01501 | 34722019 | Cureus | Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review. | 2021 | Details |
| A01504 | 34719614 | J Nutr Sci Vitaminol (Tokyo) | Effect of Hyperbaric Oxygen Therapy (HBOT) on Insulin Resistance Associated with Abdominal Obesity in Wistar Rats with Dietary Sucrose-Induced Metabolic Syndrome. | 2021 | Details |
| A01507 | 34717726 | Trials | Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study). | 2021 | Details |
| A01510 | 34716911 | Hormones (Athens) | Association of cardiovascular factors in diabetic patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A01518 | 34711595 | BMJ Open | Association between complement C3 and the prevalence of metabolic-associated fatty liver disease in a Chinese population: a cross-sectional study. | 2021 | Details |
| A01519 | 34710938 | Z Gastroenterol | Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of osteoporosis and bone fractures. | 2021 | Details |
| A01520 | 34710482 | J Hepatol | Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. | 2021 | Details |
| A01521 | 34710382 | Am J Pathol | A Novel Mouse Model of Nonalcoholic Steatohepatitis Suggests that Liver Fibrosis Initiates around Lipid-Laden Macrophages. | 2021 | Details |
| A01525 | 34708066 | Front Nutr | Integrated Transcriptomic and Translatomic Inquiry of the Role of Betaine on Lipid Metabolic Dysregulation Induced by a High-Fat Diet. | 2021 | Details |
| A01532 | 34707258 | Nat Rev Gastroenterol Hepatol | Advancing the global public health agenda for NAFLD: a consensus statement. | 2021 | Details |
| A01537 | 34706542 | J Agric Food Chem | Sulforaphane Regulates Glucose and Lipid Metabolisms in Obese Mice by Restraining JNK and Activating Insulin and FGF21 Signal Pathways. | 2021 | Details |
| A01543 | 34704005 | JHEP Rep | PI3Kγ promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation. | 2021 | Details |
| A01550 | 34697666 | Handb Exp Pharmacol | Obesity and Obstructive Sleep Apnea. | 2021 | Details |
| A01555 | 34695228 | Eur J Clin Invest | Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non-alcoholic steatohepatitis. | 2021 | Details |
| A01561 | 34693238 | JHEP Rep | Non-invasive biomarkers of Fontan-associated liver disease. | 2021 | Details |
| A01562 | 34693236 | JHEP Rep | Non-alcoholic fatty liver disease: A patient guideline. | 2021 | Details |
| A01566 | 34690666 | Int J Public Health | Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis. | 2021 | Details |
| A01574 | 34688661 | J Biol Chem | A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease. | 2021 | Details |
| A01575 | 34688168 | Curr Opin Pharmacol | Non-alcoholic fatty liver disease: Current therapeutic options. | 2021 | Details |
| A01584 | 34684698 | Molecules | Natural Aporphine Alkaloids with Potential to Impact Metabolic Syndrome. | 2021 | Details |
| A01586 | 34684586 | Nutrients | Time-Restricted Feeding during Puberty Ameliorates Adiposity and Prevents Hepatic Steatosis in a Mouse Model of Childhood Obesity. | 2021 | Details |
| A01587 | 34684533 | Nutrients | Supplementation with a Specific Combination of Metabolic Cofactors Ameliorates Non-Alcoholic Fatty Liver Disease, Hepatic Fibrosis, and Insulin Resistance in Mice. | 2021 | Details |
| A01588 | 34684510 | Nutrients | Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis. | 2021 | Details |
| A01593 | 34684339 | Nutrients | Ethanol Extract of Liriope platyphylla Root Attenuates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice via Regulation of Lipogenesis and Lipid Uptake. | 2021 | Details |
| A01594 | 34684335 | Nutrients | Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets. | 2021 | Details |
| A01599 | 34681787 | Int J Mol Sci | The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01612 | 34680476 | Biomedicines | Genetics Is of the Essence to Face NAFLD. | 2021 | Details |
| A01613 | 34680463 | Biomedicines | Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges. | 2021 | Details |
| A01623 | 34678296 | Clin Chim Acta | The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. | 2021 | Details |
| A01624 | 34677420 | Metabolites | Molecular Mechanisms of the SLC13A5 Gene Transcription. | 2021 | Details |
| A01629 | 34676233 | Front Nutr | NAFLD and Physical Exercise: Ready, Steady, Go! | 2021 | Details |
| A01631 | 34675931 | Front Immunol | Tim-1 Deficiency Aggravates High-Fat Diet-Induced Steatohepatitis in Mice. | 2021 | Details |
| A01635 | 34675003 | Diabetes | Hepatic CPT1A Facilitates Liver-Adipose Cross-Talk via Induction of FGF21 in Mice. | 2021 | Details |
| A01642 | 34670068 | Ann Pediatr Endocrinol Metab | Wilson disease diagnosed incidentally by targeted gene panel sequencing in a Korean boy with severe obesity. | 2021 | Details |
| A01649 | 34668765 | J Med Food | Ameliorative Effect of Myricetin on Nonalcoholic Fatty Liver Disease in ob/ob Mice. | 2021 | Details |
| A01655 | 34666025 | Clin Chim Acta | Gut microbiome and metabolic response in non-alcoholic fatty liver disease. | 2021 | Details |
| A01657 | 34665236 | J Mol Cell Biol | cGAS‒STING signaling and function in metabolism and kidney diseases. | 2021 | Details |
| A01660 | 34664288 | J Food Biochem | Sesamol ameliorates hepatic lipid accumulation and oxidative stress in steatosis HepG2 cells via the PPAR signaling pathway. | 2021 | Details |
| A01662 | 34663576 | Diabetes | Active Brown Adipose Tissue is Associated With a Healthier Metabolic Phenotype in Obesity. | -- | Details |
| A01664 | 34662928 | Pediatr Obes | Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction. | 2021 | Details |
| A01670 | 34660454 | J Family Med Prim Care | Association of Obstructive Sleep Apnea with Nocturnal Hypoxemia in Metabolic-Associated Fatty Liver Disease Patients: A Cross-sectional Analysis of Record-based Data. | 2021 | Details |
| A01671 | 34660070 | Cureus | A Retrospective Study of Hospitalizations in the USA: Proportion of Hospitalizations With Non-Alcoholic Fatty Liver Disease in Non-Obese Population. | 2021 | Details |
| A01678 | 34657611 | Lipids Health Dis | Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study. | 2021 | Details |
| A01684 | 34654976 | Curr Gastroenterol Rep | Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician's Guide. | 2021 | Details |
| A01688 | 34653686 | Ann Hepatol | Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016. | 2021 | Details |
| A01689 | 34653601 | J Nutr Biochem | Copper (Cu) induced changes of lipid metabolism through oxidative stress-mediated autophagy and Nrf2/PPARγ pathways. | 2021 | Details |
| A01696 | 34651580 | J Clin Invest | Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2. | 2021 | Details |
| A01708 | 34648769 | Metabolism | Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study. | 2021 | Details |
| A01714 | 34646233 | Front Endocrinol (Lausanne) | Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders. | 2021 | Details |
| A01718 | 34641807 | BMC Geriatr | A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80. | 2021 | Details |
| A01724 | 34638880 | Int J Mol Sci | A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity. | 2021 | Details |
| A01729 | 34635626 | Gut Liver | Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease. | 2022 | Details |
| A01731 | 34634561 | Biomed Pharmacother | Jaboticaba (Myrciaria jaboticaba) powder consumption improves the metabolic profile and regulates gut microbiome composition in high-fat diet-fed mice. | 2021 | Details |
| A01736 | 34632700 | Mol Nutr Food Res | Improvement of Non-Alcoholic Fatty Liver Disease in Mice by Intermittent Use of a Fasting-Mimicking Diet. | 2021 | Details |
| A01739 | 34631140 | Obes Sci Pract | "Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD". | 2021 | Details |
| A01744 | 34630869 | World J Hepatol | Coronavirus disease 2019 and non-alcoholic fatty liver disease. | 2021 | Details |
| A01745 | 34630157 | Front Physiol | Effect of Exercise Training on Fat Loss-Energetic Perspectives and the Role of Improved Adipose Tissue Function and Body Fat Distribution. | 2021 | Details |
| A01751 | 34629064 | Lipids Health Dis | Lipid biomarkers and Cancer risk - a population-based prospective cohort study in Taiwan. | 2021 | Details |
| A01752 | 34629059 | Lipids Health Dis | The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease. | 2021 | Details |
| A01753 | 34629056 | Lipids Health Dis | Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China. | 2021 | Details |
| A01754 | 34629052 | Lipids Health Dis | Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico. | 2021 | Details |
| A01757 | 34628102 | Atherosclerosis | IDO activity forecasts obesity in males and premenopausal females in a 10-year follow-up study:The Cardiovascular Risk in Young Finns Study. | 2021 | Details |
| A01761 | 34627692 | Nutr Metab Cardiovasc Dis | Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes society. | 2021 | Details |
| A01762 | 34626855 | Mol Metab | The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis. | 2021 | Details |
| A01765 | 34626589 | J Lipid Res | Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70-/- mice by reducing fat absorption. | 2021 | Details |
| A01769 | 34624198 | Expert Rev Gastroenterol Hepatol | Current epidemiology in hepatocellular carcinoma. | 2021 | Details |
| A01770 | 34622555 | Diabetes Obes Metab | Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes. | 2021 | Details |
| A01774 | 34621822 | World J Clin Cases | Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus. | 2021 | Details |
| A01782 | 34619105 | Lancet Diabetes Endocrinol | COVID-19 and metabolic disease: mechanisms and clinical management. | 2021 | Details |
| A01783 | 34619074 | Cell Metab | Molecular aspects of fructose metabolism and metabolic disease. | 2021 | Details |
| A01789 | 34617207 | Obes Surg | Religious Fasting of Muslim Patients After Metabolic and Bariatric Surgery: a Modified Delphi Consensus. | 2021 | Details |
| A01799 | 34610926 | BMJ Open Gastroenterol | Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt. | 2021 | Details |
| A01800 | 34610720 | Diabetes Metab J | Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases. | 2021 | Details |
| A01801 | 34610207 | Liver Int | Association of genetic variations with NAFLD in lean individuals. | 2021 | Details |
| A01802 | 34609305 | Turk J Gastroenterol | Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis. | 2021 | Details |
| A01812 | 34606913 | J Hepatol | Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus. | 2021 | Details |
| A01816 | 34606532 | Food Funct | Beneficial impacts of fermented celery (Apium graveolens L.) juice on obesity prevention and gut microbiota modulation in high-fat diet fed mice. | 2021 | Details |
| A01818 | 34604973 | Eur Rev Med Pharmacol Sci | Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review. | 2021 | Details |
| A01829 | 34602251 | Gastroenterology | Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01833 | 34601002 | Mol Cell Endocrinol | Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation. | 2021 | Details |
| A01836 | 34600906 | Metabolism | The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study. | 2021 | Details |
| A01838 | 34598315 | Immun Inflamm Dis | Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation. | 2021 | Details |
| A01846 | 34591986 | Hepatology | OTUB1 alleviates NASH through inhibition of the TRAF6-ASK1 signaling pathways. | 2021 | Details |
| A01849 | 34590386 | Pediatr Transplant | Hepatic macrosteatosis in the US pediatric deceased liver donor population. | 2021 | Details |
| A01851 | 34589520 | Front Mol Biosci | Saliva and Plasma Reflect Metabolism Altered by Diabetes and Periodontitis. | 2021 | Details |
| A01856 | 34587729 | Zhonghua Yi Xue Za Zhi | [Clinical features and risk factors of metabolic syndrome in adult hypopituitary patients]. | 2021 | Details |
| A01860 | 34585892 | J Assoc Physicians India | Management of Hyperglycemia in COVID-19 and Post-COVID-19 Syndrome - Proposed Guidelines for India. | 2021 | Details |
| A01863 | 34584580 | Prz Gastroenterol | Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis. | 2021 | Details |
| A01866 | 34580427 | Pediatr Res | Predictors of non-alcoholic fatty liver disease in children. | 2021 | Details |
| A01874 | 34578806 | Nutrients | Independent Dose-Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01879 | 34575934 | Int J Mol Sci | The Anti-Atherosclerotic Action of FFAR4 Agonist TUG-891 in ApoE-Knockout Mice Is Associated with Increased Macrophage Polarization towards M2 Phenotype. | 2021 | Details |
| A01882 | 34574082 | Foods | AGL9: A Novel Hepatoprotective Peptide from the Larvae of Edible Insects Alleviates Obesity-Induced Hepatic Inflammation by Regulating AMPK/Nrf2 Signaling. | 2021 | Details |
| A01887 | 34572442 | Biomedicines | Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01891 | 34572151 | Cells | Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology. | 2021 | Details |
| A01893 | 34571189 | J Nutr Biochem | Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice. | 2021 | Details |
| A01899 | 34567270 | Therap Adv Gastroenterol | Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey. | 2021 | Details |
| A01905 | 34565765 | J Atheroscler Thromb | Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication. | 2021 | Details |